Publications by authors named "Heming Zhou"

Claim this Profile
T
Targeting of the mA eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer.
Heming Zhou, Huarong Chen, Weixin Liu, Cong Liang, Shiyan Wang

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
YTHDF1 targets the chemotherapy response by suppressing NOTCH1-induced stemness in colorectal cancer.
Henley Cheung, Huarong Chen, Danyu Chen, Heming Zhou, Cong Liang

Signal Transduct Target Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut-liver translocation of pathogen Klebsiella pneumoniae promotes hepatocellular carcinoma in mice.
Xueliang Wang, Yi Fang, Wei Liang, Yuhong Cai, Chi Chun Wong, Xingyu Zhou, Heming Zhou

Nat Microbiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of RhoGEF/RhoA alleviates regorafenib resistance and cancer stemness via Hippo signaling pathway in hepatocellular carcinoma.
He-Ming Zhou, Da-Hong Chen, Wen-Jing Diao, Ya-Fei Wu, Ji-Gang Zhang

Exp Cell Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.
Huihua Yang, Dahong Chen, Yafei Wu, Heming Zhou, Wenjing Diao

Cancer Metab· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of daurisoline treatment in hepatocellular carcinoma: Inhibiting vasculogenic mimicry formation and enhancing sensitivity to sorafenib.
Xue Zhang, Ji-Gang Zhang, Wan Mu, He-Ming Zhou, Gao-Lin Liu

Phytomedicine· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents.
He-Ming Zhou, Ji-Gang Zhang, Xue Zhang, Qin Li

Signal Transduct Target Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rho kinase mediates transforming growth factor-β1-induced vasculogenic mimicry formation: involvement of the epithelial-mesenchymal transition and cancer stemness activity.
Xue Zhang, Jigang Zhang, Heming Zhou, Gaolin Liu, Qin Li

Acta Biochim Biophys Sin (Shanghai)· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Stem Cells: A Potential Breakthrough in HCC-Targeted Therapy.
Yafei Wu, Jigang Zhang, Xue Zhang, Heming Zhou, Gaolin Liu

Front Pharmacol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
Ji-Gang Zhang, He-Ming Zhou, Xue Zhang, Wan Mu, Juan-Ni Hu

BMC Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.
Xue Zhang, Jigang Zhang, Heming Zhou, Guorong Fan, Qin Li

J Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlapping and unique roles played by ROCK1 and 2 in the modulation of coding and long noncoding RNA expression.
He-Ming Zhou, Ji-Gang Zhang, Xue Zhang, Guo-Rong Fan, Gao-Lin Liu

BMC Genomics· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis